Seidamir Pasha Tabaeian
Overview
Explore the profile of Seidamir Pasha Tabaeian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
95
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dana F, Mahjoub S, Shokati Eshkiki Z, Namazi A, Tabaeian S, Akbari A
Mol Biol Res Commun
. 2025 Mar;
14(2):157-166.
PMID: 40028475
The expression level of exosomal long non-coding RNAs (lncRNAs) can be relevant for clinical diagnostic approaches. The object of our study was to evaluate the differential expression of lncRNAs colon...
2.
Kazemi Nodeh A, Shokati Eshkiki Z, Ahifar A, Soltani B, Agah S, Masoodi M, et al.
Asian Pac J Cancer Prev
. 2025 Mar;
26(2):497-504.
PMID: 40022694
Background: Pyroptosis can play a significant role in the development of inflammatory bowel diseases such as ulcerative colitis (UC) and colorectal cancer (CRC). The expression pattern of two pyroptosis related-lncRNAs...
3.
Tabaeian S, Moeini S, Rezapour A, Afshari S, Souresrafil A, Barzegar M
BMJ Open Gastroenterol
. 2025 Jan;
11(1).
PMID: 39797661
Objectives: Our aim was to systematically review the cost-effectiveness of proton pump inhibitor (PPI) therapies and surgical interventions for gastro-oesophageal reflux disease (GORD). Design: The study design was a systematic...
4.
Akbari A, Adabi M, Masoodi M, Namazi A, Mansouri F, Tabaeian S, et al.
Front Artif Intell
. 2025 Jan;
7:1446693.
PMID: 39764458
One of the foremost causes of global healthcare burden is cancer of the gastrointestinal tract. The medical records, lab results, radiographs, endoscopic images, tissue samples, and medical histories of patients...
5.
Anoushirvani A, Tabaeian S, Maarefi M, Basir Shabestari S
Med J Islam Repub Iran
. 2024 Dec;
38:85.
PMID: 39678767
Background: Both coronavirus disease-2019 (COVID-19) and cancer place a heavy burden on the society and mental health of patients. Spiritual health may play a prominent role in coping with stressful...
6.
Tavakolian S, Shokati Eshkiki Z, Akbari A, Faghihloo E, Tabaeian S
Pathol Res Pract
. 2024 Dec;
266:155749.
PMID: 39642806
Despite advancements in science, researchers still face challenges in curing patients with malignancies. This health issue is linked to various risk factors, including alcohol consumption, age, sex, and infectious diseases....
7.
The dysregulation and clinical relevance of lncRNAs MYOSLID and SFTA1P in colorectal cancer patients
Karamzadeh A, Heidari M, Namazi A, Tabaeian S, Akbari A
Mol Biol Rep
. 2024 Oct;
51(1):1109.
PMID: 39476151
Background: Colorectal cancer (CRC) is a very common cancer worldwide. CRC is characterized by some changes in the expression of oncogenic and tumor suppressor genes. These changes are associated with...
8.
Rostami M, Mahmoudi T, Ardalani A, Mashaollahi A, Zafarjafarzadeh N, Mahban A, et al.
Per Med
. 2024 Oct;
21(6):367-372.
PMID: 39469878
Nonalcoholic fatty liver disease (NAFLD) is a significant health issue worldwide. This study investigated the effect of the adiponectin receptor 1 gene () polymorphism on susceptibility to NAFLD. Data from...
9.
Asadi A, Rostami M, Shafiee R, Ardalani A, Dehghanitafti A, Golshadi Z, et al.
Arch Endocrinol Metab
. 2024 Oct;
68:e230216.
PMID: 39420901
Objective: This study was designed to investigate the possible effect of the insulin receptor substrate 1 gene rs1801276 polymorphism on the risk of nonalcoholic fatty liver disease (NAFLD). Subjects And...
10.
Nouri S, Navari M, Shafiee R, Mahmoudi T, Rezamand G, Asadi A, et al.
Rev Assoc Med Bras (1992)
. 2024 Jul;
70(7):e20231537.
PMID: 39045929
Objectives: Nonalcoholic fatty liver disease is the term used for a range of conditions in which fat builds up in the liver and exceeds 5% of hepatocytes without inordinate alcohol...